<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04341909</url>
  </required_header>
  <id_info>
    <org_study_id>TIERS</org_study_id>
    <nct_id>NCT04341909</nct_id>
  </id_info>
  <brief_title>Trainee Involvement in ERCP Risk Score</brief_title>
  <acronym>TIERS</acronym>
  <official_title>Trainee Involvement in ERCP Risk Score</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Colentina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Policlinico Gemelli, Rome, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cantacuzino Clinical Hospital, Bucharest, Romania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zadar Hospital, Zadar, Croatia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Belgrade Medical School, Belgrade, Serbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UHC Zagreb, Zagreb, Croatia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oxford University Hospital, Oxford, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University, Sofia, Bulgaria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Hospital Colentina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to evaluate factors associated with an increased risk of procedure related
      adverse events (including tecnical failure) of endoscopic retrograde cholangiopancreatography
      procedures (ERCP) conducted in a teaching setting, with trainee involvement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to evaluate factors associated with an increased risk of procedure related
      adverse events (including tecnical failure) of endoscopic retrograde cholangiopancreatography
      procedures (ERCP) conducted in a teaching setting, with trainee involvement.

      It has previously shown that ERCP procedures with trainee involvement have no additional risk
      for the patient, but we aim to evaluate whether a subgroup of high-risk procedures can be
      identified to allow an improvement of the teaching of ERCP, including identifying some high
      risk features that might indicate that trainee involvement should not be warranted.

      Briefly, the study is observational in nature and aims to gather clinical data about the
      patient and technical data about the procedure (including the degree of trainee involvement(
      to assess which (if any) procedures carry a higher risk for the patient in a training
      setting.

      data will be gathered using a standard report form completed by the attending endoscopist at
      the end of each procedure; the form will then be updated at 30days interval with data about
      potential adverse events.

      Patient identity will be protected throughout the study as per regulations in each
      institution and country; also all patients will sign an informed consent prior to the
      endoscopic procedure and study enrollment.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>any procedure related adverse outcome</measure>
    <time_frame>30 days</time_frame>
    <description>including but not limited to cholangitis, perforation, bleeding, technical failure, pancreatitis</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Bile Duct Diseases</condition>
  <condition>Pancreas Cancer</condition>
  <arm_group>
    <arm_group_label>Trainee Group</arm_group_label>
    <description>Patients who undergo ERCPs with trainee involvement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>Patients who undergo ERCPs without any trainee involvement</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERCP</intervention_name>
    <description>endoscopic retrograde cholangiopancreatography</description>
    <arm_group_label>Trainee Group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all adult patients undergoing ERCP for any indication (diagnostic / therapeutic) in the
        participating centers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing ERCP in the participating centers

          -  informed consent signed prior to the procedure

        Exclusion Criteria:

          -  refusal to participate / sign the informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Colentina Clinical Hospital</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <reference>
    <citation>Voiosu T, Boskoski I, Voiosu AM, Benguș A, Ladic A, Klarin I, Bove V, Busuioc B, Rimbaș M, Rustemovic N, Mateescu B, Jovanovic I, Costamagna G. Impact of trainee involvement on the outcome of ERCP procedures: results of a prospective multicenter observational trial. Endoscopy. 2020 Feb;52(2):115-122. doi: 10.1055/a-1049-0359. Epub 2019 Nov 25.</citation>
    <PMID>31766060</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2020</study_first_posted>
  <last_update_submitted>July 14, 2020</last_update_submitted>
  <last_update_submitted_qc>July 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Colentina</investigator_affiliation>
    <investigator_full_name>dr. Theodor Alexandru Voiosu</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Bile Duct Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

